⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7249483 | 0.76 | — | — | |
| SCHEMBL7032304 | 0.75 | — | — | |
| SCHEMBL6236800 | 0.69 | — | — | |
| SCHEMBL13574808 | 0.67 | — | — | |
| SCHEMBL9798556 | 0.66 | — | — | |
| SCHEMBL9798563 | 0.66 | — | — | |
| SCHEMBL4563307 | 0.65 | NPSR1 (0.41) | — | |
| SCHEMBL8925956 | 0.65 | — | — | |
| SCHEMBL14723229 | 0.64 | SMPD3 (0.45) | — | |
| SCHEMBL11300468 | 0.63 | NPC1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3894416-B1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2022-11-09 | — | — | EP | disclosed |
| EP-3894416-B1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2022-11-09 | — | — | EP | disclosed |
| US-11286243-B2 | Ferroportin inhibitors and methods of use | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| EP-3894416-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | Global Blood Therapeutics, Inc. (US) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020123850-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020123850-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| US-20200190045-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-06-18 | — | — | US | disclosed |
| US-20200190045-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-06-18 | — | — | US | disclosed |
| CN-106803598-B | A kind of organic composite type high temperature proton exchange film and preparation method thereof | 中国科学院上海有机化学研究所 | 2019-08-16 | — | — | CN | disclosed |
| CN-106803598-A | A kind of organic composite type high temperature proton exchange film and preparation method thereof | 中国科学院上海有机化学研究所 | 2017-06-06 | — | — | CN | disclosed |
| WO-2009148687-A1 | SILICA ENCAPSULATED ORGANIC NANOPIGMENTS AND METHOD OF MAKING SAME | XEROX CORPORATION (US) | 2009-12-10 | — | — | WO | disclosed |
| WO-2009126388-A1 | ENCAPSULATED NANOSCALE PARTICLES OF ORGANIC PIGMENTS | XEROX CORPORATION (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-0828763-A1 | POLYMER AND SURFACTANT MIXTURES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-18 | — | — | EP | disclosed |
| EP-0765379-A1 | COLOR MIGRATION INHIBITORS FOR WASHING AND CLEANING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-02 | — | — | EP | disclosed |
| WO-1996037524-A1 | POLYMER AND SURFACTANT MIXTURES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-28 | — | — | WO | disclosed |
| WO-1996037598-A1 | DYE TRANSFER INHIBITORS FOR DETERGENTS CONTAINING BLEACHING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-28 | — | — | WO | disclosed |
| EP-0731813-A1 | POLYMERS OF ALKYL-1-VINYLIMIDAZOLES | BASF AG (DE) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995035360-A1 | COLOR MIGRATION INHIBITORS FOR WASHING AND CLEANING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1995-12-28 | — | — | WO | disclosed |
| WO-1995015345-A1 | POLYMERS OF ALKYL-1-VINYLIMIDAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1995-06-08 | — | — | WO | disclosed |
| US-4410706-A | Preparation of 2-vinylimidazoles by dehydrogenation of 2-ethylimidazoles and 2-ethylimidazolines | AMERICAN CYANAMID COMPANY (US) | 1983-10-18 | — | — | US | disclosed |